Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique

Bone Marrow Transplantation volume 29, pages 335–339 (2002)Cite this article

Abstract

Here, the influence of T vs T and B cell depletion on the incidence of EBV-associated lymphoproliferative disorder (EBV-LPD) after bone marrow transplantation (BMT) from a matched unrelated donor (MUD) is analyzed. From 1982 to 1997 the soy bean agglutinin/sheep red blood cell (SBA/SRBC) method was used for T cell depletion. This technique is well established, but the use of SRBC has a risk of transmitting prions or viruses. Therefore, a new T cell depletion method was introduced, using CD2 and CD3 monoclonal antibodies (CD2/3 method) instead of SRBC. Unfortunately, this led to an unexpected high number of EBV-LPDs in patients receiving transplants from MUDs. SBA depletion was reintroduced and combined with the CD2/3 method (SBA/CD2/3) in this patient population, later replaced by B cell-specific (CD19 and CD22) antibodies (CD3/19/22 method). The number of T (× 105/kg) and B (× 105/kg) cells in the graft was 1.5 ± 0.8 and 2 ± 1 (T/B ratio 0.75), 2.2 ± 2.0 and 41 ± 21 (ratio 0.055), 5.0 ± 0.0 and 2 ± 1 (ratio 2.5), 2.5 ± 1.2 and 10 ± 6 (ratio 0.25) using the SBA/SRBC, CD2/3, SBA/CD2/3 and CD3/19/22 techniques, respectively. When B cell depletion was performed (SBA/SRBC, SBA/CD2/3, CD3/19/22) four out of 31 patients (13%) receiving a BMT from a MUD developed an EBV-LPD. Without B cell depletion (CD2/3) this occurred in five out of seven patients (71%) (P < 0.05). A T/B cell ratio in the graft of ⩾0.25 seems sufficient to significantly reduce the incidence of EBV-LPD after BMT from MUDs.

Bone Marrow Transplantation (2002) 29, 335–339. doi:10.1038/sj.bmt.1703362

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program New Engl J Med 1993 328: 593 602

    Article  CAS  PubMed  Google Scholar 

  2. Arnold R, de Witte T, van Biezen A et al. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT study Bone Marrow Transplant 1998 21: 1213 1216

    Article  CAS  PubMed  Google Scholar 

  3. Ferrara JLM, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667 674

    Article  CAS  PubMed  Google Scholar 

  4. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study Blood 1999 94: 2208 2216

    CAS  PubMed  Google Scholar 

  5. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation New Engl J Med 1975 292: 832 843

    Article  CAS  PubMed  Google Scholar 

  6. Verdonck LF, Dekker AW, de Gast GC et al. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft Blood 1994 83: 3090 3096

    CAS  PubMed  Google Scholar 

  7. Verdonck LF, Dekker AW, Rozenberg-Arska M, van den Hoek MR . A risk adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplantation Clin Infect Dis 1997 24: 901 907

    Article  CAS  PubMed  Google Scholar 

  8. Reisner Y, Kirkpatrick D, Dupont B et al. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells Lancet 1981 15: 327 331

    Article  Google Scholar 

  9. Slaper-Cortenbach ICM, Wijngaarden-du Bois MJGJ, de Vries-van Rossen A et al. The depletion of T cells from haematopoietic stem cell transplants Rheumatology 1999 38: 751 754

    Article  CAS  PubMed  Google Scholar 

  10. Knowles DM, Cesarman E, Chadburn A et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders Blood 1995 85: 552 565

    CAS  PubMed  Google Scholar 

  11. Baurmann H, Revillard JP, Bonnefoy-Berard N, Schwerdtfeger R . Potent effects of ATG used as part of the conditioning in matched unrelated donor transplantation Blood 1998 92: S 290A (Abstr.)

  12. Cohen JI . Epstein–Barr virus infection New Engl J Med 2000 343: 481 492

    Article  CAS  PubMed  Google Scholar 

  13. Gratama JW, Oosterveer MAP, Zwaan FE et al. Eradication of Epstein–Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency Proc Natl Acad Sci USA 1988 8: 8693 8696

    Article  Google Scholar 

  14. Gratama JW, Oosterveer MAP, Lepoutre J et al. Serological and molecular studies of Epstein–Barr virus infection in allogeneic marrow graft recipients Transplantation 1990 49: 725 730

    Article  CAS  PubMed  Google Scholar 

  15. Cavazzana M, Bensoussan D, Jabado N et al. Prevention of EBV-induced Blymphoproliferative disorder by ex vivo marrow B cell depletion in HLA-phenoidentical or non-identical T depleted bone marrow transplantation Br J Haematol 1998 103: 543 551

    Article  Google Scholar 

  16. Liu Z, Wilson JM, Jones MC et al. Addition of B cell depletion of donor marrow with anti-CD20 antibody to a T cell depletion regimen for prevention of EBV lymphoma after bone marrow transplantation Blood 1999 94: 638A (Abstr.)

    Google Scholar 

  17. Hale G, Waldmann H . Risks of developing Epstein–Barr virus-related lymphoproliferative disorders after T cell-depleted marrow transplants Blood 1998 91: 3079 3083

    CAS  PubMed  Google Scholar 

  18. van Esser JWJ, van der Holt B, Meijer E et al. Epstein–Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T cell depleted SCT Blood 2001 98: 972 978

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Hans van Heugten, Jannie van der Giessen and Lex van der Gouw for performing T and T/B cell depletions of the grafts.

Author information

Authors and Affiliations

  1. Department of Hematology, University Medical Centre, Utrecht, The Netherlands

    E Meijer, ICM Slaper-Cortenbach, AW Dekker & LF Verdonck

  2. Department of Virology, University Medical Centre, Utrecht, The Netherlands

    SFT Thijsen

Authors
  1. E Meijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. ICM Slaper-Cortenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. SFT Thijsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. AW Dekker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. LF Verdonck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meijer, E., Slaper-Cortenbach, I., Thijsen, S. et al. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 29, 335–339 (2002). https://doi.org/10.1038/sj.bmt.1703362

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703362

Keywords

This article is cited by

Search

Advanced search

Quick links